See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $698B | 13.7x | 34.8x | |
| $393B | 6.8x | 15.1x | |
| $387B | 4.3x | 11.9x | |
| $315B | 6.8x | 13.8x | |
| $154B | 5.4x | 12.5x | |
| $150B | 6.2x | 19.8x | |
| $140B | 2.8x | 9.5x | |
| $138B | 2.9x | 12.1x | |
| $109B | 9.6x | 39.7x | |
| $98.0B | 2.3x | 6.7x | |
| $87.3B | 5.6x | 16.8x | |
| $80.1B | 8.6x | 20.0x | |
| $63.9B | 1.2x | 5.8x | |
| $9.7B | 2.9x | 8.2x | |
| $7.9B | 10.3x | n/a | |
| $7.2B | 9.5x | 35.6x | |
| $7.1B | n/a | n/a | |
| $6.2B | 14.0x | 44.7x | |
| $6.0B | 6.8x | 25.0x | |
| $3.6B | 7.3x | 17.8x | |
| $3.6B | 174.3x | -6.1x | |
| $3.0B | 3.0x | 17.1x | |
| $1.9B | 2.1x | 7.1x | |
| $1.6B | 611.4x | -4.2x | |
| $1.6B | 2.3x | 3.8x | |
| $1.6B | n/a | n/a | |
| $1.5B | 1.3x | 4.2x | |
| $1.5B | 38.0x | -3.3x | |
| $1.3B | 1.0x | 2.9x | |
| $1.2B | 127.2x | -2.4x | |
| $1.1B | 1.7x | 5.9x | |
| $1.0B | n/a | n/a | |
| $953M | n/a | -6.1x | |
| $908M | 4.6x | 6.3x | |
| $834M | n/a | -2.3x | |
| $798M | 2.7x | 21.2x | |
| $746M | 8.8x | n/a | |
| $745M | 2.1x | 25.3x | |
| $713M | 1.0x | 3.8x | |
| $708M | n/a | -1.9x | |
| $599M | 1.3x | 6.1x | |
| $582M | n/a | n/a | |
| $576M | n/a | n/a | |
| $552M | 1.5x | 6.4x | |
| $499M | n/a | -2.3x | |
| $343M | 2.8x | 19.9x | |
| $320M | 30.9x | -1.9x | |
| $309M | 5.0x | -13.8x | |
| $307M | 1.2x | n/a | |
| $297M | 56.9x | n/a | |
| $295M | 1.1x | 6.4x | |
| $278M | 1.5x | -2.7x | |
| $259M | 24.9x | n/a | |
| $241M | 106.7x | -13.9x | |
| $213M | 30.4x | -2.4x | |
| $212M | n/a | n/a | |
| $212M | 0.7x | 4.6x | |
| $192M | n/a | -5.4x | |
| $190M | 3.1x | -4.1x | |
| $186M | 362.8x | n/a | |
| $177M | 1.3x | -0.9x | |
| $171M | 1.6x | n/a | |
| $171M | n/a | n/a | |
| $149M | 264.1x | n/a | |
| $140M | n/a | -4.4x | |
| $112M | 0.9x | 28.9x | |
| $111M | n/a | n/a | |
| $102M | 78.9x | -4.2x | |
| $89.6M | n/a | n/a | |
| $81.8M | 3.4x | n/a | |
| $68.5M | 2.5x | -0.3x | |
| $47.5M | 9.0x | -4.7x | |
| $42.1M | 4.8x | n/a | |
| $35.1M | 1.6x | n/a | |
| $28.5M | 6.1x | n/a | |
| $19.5M | 41.6x | n/a | |
| $19.3M | 16.7x | -13.0x | |
| $14.2M | n/a | n/a | |
| $10.2M | 6.4x | n/a | |
| $8.1M | 0.7x | n/a | |
| $7.9M | n/a | -0.3x | |
| $4.6M | 0.2x | n/a | |
| $2.6M | 0.1x | n/a | |
| -$1.8M | -1.4x | 0.0x | |
| -$15.5M | n/a | n/a | |
| -$24.0M | n/a | n/a | |
| -$29.4M | n/a | n/a | |
| -$36.4M | -2.4x | n/a | |
| -$37.0M | n/a | n/a | |
| -$39.1M | -56.8x | n/a | |
| -$83.7M | -8.4x | 0.5x | |
| -$90.0M | -36.3x | 1.5x | |
| -$92.4M | n/a | 0.6x | |
| -$130M | -80.0x | 0.6x |